GEN Exclusives

More »

GEN News Highlights

More »
Jul 3, 2008

PerkinElmer Creates Center to Advance Cord Blood Stem Cell Studies

  • PerkinElmer has established the ViaCord Research Institute™ (VRI™) to focus on investigating potential uses of umbilical cord blood-derived stem cells.

    VRI will concentrate on supporting science, technology, and medical treatments using cord blood stem cells in five key areas: cord blood technologies, emerging stem cell therapies, genetic screening, product development and related transplants.

    The institute will be led by a team of scientists and physicians including leading experts in the areas of stem cell biology, maternal-fetal medicine, obstetrics and gynecology, transplant medicine, and genetics.

    Cord blood is a noncontroversial source of stem cells with proven effect in treating more than 70 serious diseases including many cancers and immunodeficiencies, according to the PerkinElmer.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?